1. Home
  2. CDT vs UCAR Comparison

CDT vs UCAR Comparison

Compare CDT & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

SELL

Current Price

$3.89

Market Cap

2.5M

Sector

Health Care

ML Signal

SELL

Logo U Power Limited

UCAR

U Power Limited

HOLD

Current Price

$0.57

Market Cap

1.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDT
UCAR
Founded
2019
2013
Country
United States
China
Employees
N/A
80
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
1.4M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
CDT
UCAR
Price
$3.89
$0.57
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
92.9K
24.9M
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$0.04
52 Week High
$11.00
$4.98

Technical Indicators

Market Signals
Indicator
CDT
UCAR
Relative Strength Index (RSI) 56.83 49.15
Support Level $0.85 N/A
Resistance Level $4.50 $1.71
Average True Range (ATR) 0.66 0.15
MACD 0.49 0.05
Stochastic Oscillator 32.78 31.08

Price Performance

Historical Comparison
CDT
UCAR

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

Share on Social Networks: